Morbidity and mortality results from a prospective randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II and III lower rectal cancer: Japan Clinical Oncology Group study JCOG0212.S. Fujita, Yoshihisa Saida, Keiichiro Nakamura et al.|Journal of Clinical Oncology|2011Cited by 2
P-76 Phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD)N. Sugimoto, Hiroshi Eguchi, Ken Nakata et al.|Annals of Oncology|2022Cited by 1